Behavioural and biochemical studies of citalopram and WAY 100635 in rat chronic mild stress model (Q43921759)

28 November 2017

title

Behavioural and biochemical studies of citalopram and WAY 100635 in rat chronic mild stress model (English)

1 reference

Lucyna Antkiewicz-Michaluk

28 November 2017

author

series ordinal

3

object named as

Lucyna Antkiewicz-Michaluk

1 reference

28 November 2017

1

Mariusz Papp

1 reference

28 November 2017

2

Irena Nalepa

1 reference

28 November 2017

Connie Sánchez

4

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

Pharmacology, Biochemistry and Behavior

28 November 2017

published in

1 reference

28 November 2017

volume

72

1 reference

28 November 2017

issue

1-2

1 reference

28 November 2017

page(s)

465-474

1 reference

Patients With Severe Depression May Benefit From Buspirone Augmentation of Selective Serotonin Reuptake Inhibitors

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Partial 5-HT1A receptor agonist properties of (-)pindolol in combination with citalopram on serotonergic dorsal raphe cell firing in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Pindolol Induces a Rapid Improvement of Depressed Patients Treated With Serotonin Reuptake Inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Development of β-adrenergic receptor subsensitivity by antidepressants

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: an in vivo microdialysis study

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Effect of pindolol in hastening response to fluoxetine in the treatment of major depression: a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Current advances and trends in the treatment of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Selective activation of postsynaptic 5-HT1A receptors induces rapid antidepressant response.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Selective serotonin reuptake inhibitors plus pindolol. The REEP

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Electrophysiological and neurochemical evidence that pindolol has agonist properties at the 5-HT1A autoreceptor in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Augmentation with a 5-HT(1A), but not a 5-HT(1B) receptor antagonist critically depends on the dose of citalopram

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Combining pindolol and paroxetine in an animal model of chronic antidepressant action--can early onset of action be detected?

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Biochemical evidence for the regulation of central noradrenergic activity by 5-HT1A and 5-HT2 receptors: microdialysis studies in the awake and anaesthetized rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Enhancement of fluoxetine-dependent increase of extracellular serotonin (5-HT) levels by (-)-pindolol, an antagonist at 5-HT1A receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Weak antidepressant response after buspirone augmentation of serotonin reuptake inhibitors in refractory severe depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Effects of (-)-tertatolol, (-)-penbutolol and (+/-)-pindolol in combination with paroxetine on presynaptic 5-HT function: an in vivo microdialysis and electrophysiological study

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Buspirone modulates basal and fluoxetine-stimulated dialysate levels of dopamine, noradrenaline and serotonin in the frontal cortex of freely moving rats: activation of serotonin1A receptors and blockade of alpha2-adrenergic receptors underlie its a

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Autoreceptor antagonists enhance the effect of the reuptake inhibitor citalopram on extracellular 5-HT: this effect persists after repeated citalopram treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Influence of 5-HT1A receptors on central noradrenergic activity: microdialysis studies using (+/-)-MDL 73005EF and its enantiomers

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Effect of a selective 5-hydroxytryptamine reuptake inhibitor on brain extracellular noradrenaline: microdialysis studies using paroxetine

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Behavioral, neurochemical and endocrinological characterization of the early social isolation syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Pindolol occupancy of 5-HT(1A) receptors measured in vivo using small animal positron emission tomography with carbon-11 labeled WAY 100635

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

WAY100635-induced augmentation of the 5-HT-elevating action of citalopram: relative importance of the dose of the 5-HT1A (auto)receptor blocker versus that of the 5-HT reuptake inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Regulation of beta 1-adrenergic receptor mRNA and ligand binding by antidepressant treatments and norepinephrine depletion in rat frontal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Evidence from microdialysis and synaptosomal studies of rat cortex for noradrenaline uptake sites with different sensitivities to SSRIs

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Biochemical effects and drug levels in rats after long-term treatment with the specific 5-HT-uptake inhibitor, citalopram

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Where are we going with SSRIs?

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Effect of 5-HT1A receptor antagonists on citalopram-induced increase in extracellular serotonin in the frontal cortex, striatum and dorsal hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Effect of long-term administration of antidepressant drugs on the 5-HT3 receptors that enhance the electrically evoked release of [3H]noradrenaline in the rat hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Dopaminergic mechanism of imipramine action in an animal model of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Involvement of protein kinase C in the mechanism of in vitro effects of imipramine on generation of second messengers by noradrenaline in cerebral cortical slices of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Enhancement of the responsiveness of cortical adrenergic receptors by chronic administration of the 5-hydroxytryptamine uptake inhibitor citalopram

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Agonist and antagonist actions of (-)pindolol at recombinant, human serotonin1A (5-HT1A) receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Up-regulation of beta 1-adrenergic receptors in rat brain after chronic citalopram and fluoxetine treatments

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Reversal by imipramine of beta-adrenoceptor up-regulation induced in a chronic mild stress model of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Effects of imipramine on serotonergic and beta-adrenergic receptor binding in a realistic animal model of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Chronic treatment with citalopram induces noradrenaline receptor hypoactivity. A microdialysis study.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

In vivo serotonin release and learned helplessness

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

The effect of 5-HT1A receptor ligands in a chronic mild stress model of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Dose-dependent influence of buspirone on the activities of selective serotonin reuptake inhibitors in the mouse forced swimming test

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

The role of 5-HT1A and 5-HT1B receptors in antidepressant drug actions in the mouse forced swimming test

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Effect of pindolol on the function of pre- and postsynaptic 5-HT1A receptors: in vivo microdialysis and electrophysiological studies in the rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

The 5-HT1A antagonist WAY-100635 selectively potentiates the presynaptic effects of serotonergic antidepressants in rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

A highly sensitive adenylate cyclase assay

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression. Are they all alike?

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

The selective sigma2 ligand Lu 28-179 has an antidepressant-like profile in the rat chronic mild stress model of depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

A radioisotopic method for measuring the formation of adenosine 3',5'-cyclic monophosphate in incubated slices of brain

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

5-HT(1A) agonist potential of pindolol: electrophysiologic studies in the dorsal raphe nucleus and hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Buspirone augmentation of selective serotonin reuptake inhibitors (SSRIs) in social phobia

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Antidepressants: past, present and future

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Action of various antidepressant treatments reduces reactivity of noradrenergic cyclic AMP-generating system in limbic forebrain

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

10.1016/S0091-3057(01)00778-X

Identifiers

DOI

1 reference

28 November 2017

1 reference